European Diabetes Leadership Forum Participation Report
date : 4/26/2012
HGPI Director Ryoji Noritake recently participated in the European Diabetes Leadership Forum, held on the 25-26 April 2012 in Denmark, the EU presidency holder country for the first half of 2012.
This forum was held as a meeting for high-level discussions on how diabetes control could act as a model case for progression in the area of chronic disease control. It aimed to reflect on the magnitude of the influence of diabetes prevalence in Europe, and hold discussions from the perspective of prevention, early detection, and improvement of treatment. The forum was organized by the Organization for Economic Co-operation and Development (OECD) together with the Danish Diabetes Association (DDA), with backing from the Danish government and Danish Health Ministry and support from the company Novo Nordisk. Around 760 people attended, with participants representing government, industry, academia, and patients present from all over the world, including EU Member States, European Free Trade Association Member States, EU non-member states, and OECD Member States.
Speeches were also made by the Danish Prime Minister and Minister of Health and Welfare, as well as Kofi Annan, former U.N. Secretary-General. The importance of comprehensive approaches which transcend health policy frameworks was emphasized, together with the importance of policies which bridge patient and multi-stakeholder involvement in prevention with treatment. Furthermore, it was also re-recognized that diabetes control does not just end with the formulation of a road map as actual implementation is also important, and to this end patient empowerment and cooperative activities between different sectors were highlighted as being additionally important.
This forum was held as a meeting for high-level discussions on how diabetes control could act as a model case for progression in the area of chronic disease control. It aimed to reflect on the magnitude of the influence of diabetes prevalence in Europe, and hold discussions from the perspective of prevention, early detection, and improvement of treatment. The forum was organized by the Organization for Economic Co-operation and Development (OECD) together with the Danish Diabetes Association (DDA), with backing from the Danish government and Danish Health Ministry and support from the company Novo Nordisk. Around 760 people attended, with participants representing government, industry, academia, and patients present from all over the world, including EU Member States, European Free Trade Association Member States, EU non-member states, and OECD Member States.
Speeches were also made by the Danish Prime Minister and Minister of Health and Welfare, as well as Kofi Annan, former U.N. Secretary-General. The importance of comprehensive approaches which transcend health policy frameworks was emphasized, together with the importance of policies which bridge patient and multi-stakeholder involvement in prevention with treatment. Furthermore, it was also re-recognized that diabetes control does not just end with the formulation of a road map as actual implementation is also important, and to this end patient empowerment and cooperative activities between different sectors were highlighted as being additionally important.
Exhibition date：2012-04-26
Top Research & Recommendations Posts
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Research Report] The 2026 Public Opinion Survey on Healthcare in Japan (February 13, 2026)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022）
- [Research Report] 2019 Survey on Healthcare in Japan
- [Research Report] The Public Opinion Survey on Child-Rearing in Modern Japan (Final Report) (March 4, 2022)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Policy Recommendations] Mental Health Project: Recommendations on Three Issues in the Area of Mental Health (July 4, 2025)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
Featured Posts
-
2026-02-13
[Research Report] The 2026 Public Opinion Survey on Healthcare in Japan (February 13, 2026)
![[Research Report] The 2026 Public Opinion Survey on Healthcare in Japan (February 13, 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/HGPI_The2026PublicOpinionSurveyOnHealthcareInJapan_20260213.jpg)
-
2026-03-03
[Registration Open] Online Seminar “Implementing Chronic Kidney Disease (CKD) Measures into Society: Towards a Data-Driven Health System” (April 21, 2026)
![[Registration Open] Online Seminar “Implementing Chronic Kidney Disease (CKD) Measures into Society: Towards a Data-Driven Health System” (April 21, 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/HGPI_20260421_CKDonlineseminar-.png)
-
2026-03-16
[Research Report] Energy Conservation and Greenhouse Gas Emissions Reduction in Healthcare Facilities: Case Studies from New Construction and Facility Renewal (March 16, 2026)
![[Research Report] Energy Conservation and Greenhouse Gas Emissions Reduction in Healthcare Facilities: Case Studies from New Construction and Facility Renewal (March 16, 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/HGPI_20260316_GHG-Reduction-Case-Studies.jpg)
